Comtan is an active pharmaceutical ingredient with a nitrile-containing and aromatic-ring structure. It is investigated for use in pharmaceutical manufacturing related to enzyme inhibition.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 130929-57-6
Comtan
pharmaceutical raw material
Spiroalmotriptan
pharmaceutical raw material
2H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4S,12aR)-
pharmaceutical raw material
Diatrizoate meglumine
pharmaceutical raw material
Dioxybenzone
pharmaceutical raw material
(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide
JRURYQJSLYLRLN-BJMVGYQFSA-N
CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N